Roy, E., Boivin, J. - F., & Leclerc, P. (2013). Initiation aux drogues injectables chez les jeunes de la rue : une analyse en fonction du genre. Les abrégés de recherche du RISQ, , 2.
Abstract: Au Canada, on estime que 30 à 40 % des jeunes de la rue ont recours à l’utilisation de drogues injectables. Plusieurs études suggèrent que l’initiation à ce type de consommation est influencée par le sexe et l’âge des individus. Les auteurs de cette étude se sont intéressés aux facteurs de risques à l’origine de cette initiation, selon le genre.
Keywords: AOD use, abuse, and dependence; intravenous drug user; adolescent; homeless; sex; gender; risk factors; statistical data; Canada
|
Pfäffli, M., Oswald, F., & Weinmann, W. (2013). Urinschnelltests (Immunoassays) auf Drogen und Medikamente : Wissenswertes für den Arzt. Schweizerisches Medizin-Forum = Forum médical suisse = Swiss medical forum, 13(16; 04/2013), 318–322.
Abstract: - Urinschnelltests sind ein häufig genutztes, einfaches und kostengünstiges Verfahren zur Dokumentation einer (Nicht-)Einnahme von Drogen und Medikamenten. – Urinschnelltests können bei einer Reihe häufig verwendeter Medikamentenwirkstoffe falsch-positive Reaktionen zeigen. – Die Resultate von Urinschnelltests haben aufgrund der möglichen Kreuzreaktionen lediglich hinweisenden, jedoch nicht beweisenden Charakter. – Vom Betroffenen bestrittene positive Resultate müssen mittels einer Bestätigungsanalyse überprüft werden. – Eine passive Cannabisexposition als Ursache eines positiven Cannabis-Urinschnelltests ist im Allgemeinen als Schutzbehauptung anzusehen. – Opiatkonsum, Codeineinnahme und Genuss von Mohnsamen (Mohnkuchen etc.) können nicht mittels (nicht-apparativen) Schnelltests unterschieden werden.
Keywords: screening and diagnostic method for AOD use; urinalysis; physician; illicit drug; cannabis; opioids in any form; codeine; recommendations or guidelines
|
Pfäffli, M., Oswald, F., & Weinmann, W. (2013). Recherche de drogues et de médicaments par tests rapides d'urine (immuno-essais) : informations utiles pour les médecins. Schweizerisches Medizin-Forum = Forum médical suisse = Swiss medical forum, 13(16; 04/2013), 318–322.
Abstract: - L’analyse d’urine rapide est un procédé fréquemment utilisé, simple et économique afin de documenter une prise (ou non) de drogues et de médicaments. – Pour de nombreux principes actifs couramment utilisés, l’analyse d’urine rapide peut présenter une réaction faussement positive. – En raison des réactions croisées potentielles, le résultat d’une analyse d’urine rapide est purement indicatif et n’est en rien probant. – Les résultats positifs contestés doivent être vérifiés grâce à une analyse de confirmation. – Généralement, l’explication d’une analyse d’urine rapide positive par une exposition passive au cannabis doit être considérée comme un argument de défense. – La consommation d’opiacées, de graines de pavot (gâteau aux graines de pavot, etc.) et la prise de codéine
Keywords: screening and diagnostic method for AOD use; urinalysis; physician; illicit drug; cannabis; opioids in any form; codeine; recommendations or guidelines
|
Ott, R., & Biller-Andorno, N. (2013). La signification du neuroenhancement dans la pratique médicale. Bulletin des médecins suisses, 94(13-14; 27.03.2013), 504–506.
Abstract: Présentation des résultats de l’étude “La signification du neuroenhancement pour les praticiennes et praticiens des domaines de la psychiatrie/psychothérapie et de la médecine de premier recours”, qui a visé à mieux comprendre les expériences et la position des médecins confrontés à des demandes pour des produits de neuroenhancement dans leurs cabinets.
Keywords: research chemical; designer drug; treatment-provider-patient relations; physician; psychotherapy; psychiatric care; statistical data; survey
|
Ott, R., & Biller-Andorno, N. (2013). Die Bedeutung des Neuroenhancements in der ärztlichen Praxis. Schweizerische Ärztezeitung, 94(13-14; 27.03.2013), 504–506.
Abstract: Vorgestellt werden Ergebnisse der Studie “Bedeutung des Neuroenhancements für praktizierende ÄrztInnen im Bereich Psychiatrie und Psychotherapie sowie im Bereich der Hausarztmedizin”. Diese Untersuchung zielte darauf ab, Erfahrungen und Einstellungen von Ärzten, die in ihrer Praxis mit der Nachfrage nach Neuroenhancement-Produkten konfrontiert werden, besser zu verstehen.
Keywords: research chemical; designer drug; treatment-provider-patient relations; physician; psychotherapy; psychiatric care; statistical data; survey
|
Mathers, B. M., Degenhardt, L., Bucello, C., Lemon, J., Wiessing, L., & Hickman, M. (2013). Mortality among people who inject drugs : a systematic review and meta-analysis. Bulletin of the World Health Organization, 91(2; 02/2013), 102–123.
Abstract: Objective To systematically review cohort studies of mortality among people who inject drugs, examine mortality rates and causes of death in this group, and identify participant- and study-level variables associated with a higher risk of death. Methods Tailored search strings were used to search EMBASE, Medline and PsycINFO. The grey literature was identified through online grey literature databases. Experts were consulted to obtain additional studies and data. Random effects meta-analyses were performed to estimate pooled crude mortality rates (CMRs) and standardized mortality ratios (SMRs). Findings Sixty-seven cohorts of people who inject drugs were identified, 14 of them from low- and middle-income countries. The pooled CMR was 2.35 deaths per 100 person–years (95% confidence interval, CI: 2.12–2.58). SMRs were reported for 32 cohorts; the pooled SMR was 14.68 (95% CI: 13.01–16.35). Comparison of CMRs and the calculation of CMR ratios revealed mortality to be higher in low- and middle-income country cohorts, males and people who injected drugs that were positive for human immunodeficiency virus (HIV). It was also higher during off-treatment periods. Drug overdose and acquired immunodeficiency syndrome (AIDS) were the primary causes of death across cohorts. Conclusion Compared with the general population, people who inject drugs have an elevated risk of death, although mortality rates vary across different settings. Any comprehensive approach to improving health outcomes in this group must include efforts to reduce HIV infection as well as other causes of death, particularly drug overdose.
Keywords: AOD user; intravenous drug user; risk; AODR mortality; AOD overdose mortality; viral disease; communicable disease; HIV infection; Aids; statistical data; meta-analysis; international area
|
Eckmann, F. (2013). Die schnelle Web 2.0-Generation. Akzent Magazin, (1; 05/2013), 6.
Keywords: treatment and maintenance; inpatient care; outpatient care; chemical addiction; opioids in any form; heroin; heroin-assisted treatment; methadone; cocaine; AOD dependent; demographic change
|
Carobbio Guscetti, M., & Favrod-Coune, T. (2013). La révision de la loi sur l'alcool – une pierre angulaire de la politique de santé. Bulletin des médecins suisses, 94(11; 13.03.2013), 411.
Abstract: La révision totale de la loi sur l’alcool est actuellement débattue au Parlement. Les auteurs sont convaincus que cette loi n’atteindra son objectif en matière de santé publique que si les mesures de libéralisation proposées s’accompagnent d’autres mesures de prévention cohérentes.
Keywords: government and politics; laws and regulations; amendment; chemical addiction; alcohol; prevention; Switzerland
|
Carobbio Guscetti, M., & Favrod-Coune, T. (2013). Alkoholgesetzrevision – ein gesundheitspolitischer Meilenstein. Schweizerische Ärztezeitung, 94(11; 13.03.2013), 411.
Abstract: Die Totalrevision des Alkoholgesetzes befindet sich aktuell in parlamentarischer Beratung. Die Autoren sind überzeugt, dass diese ihr gesundheitspolitisches Ziel nur erreicht, wenn den vorgeschlagenen Liberalisierungsmassnahmen kohärente Präventionsmassnahmen zur Seite gestellt werden.
Keywords: government and politics; laws and regulations; amendment; chemical addiction; alcohol; prevention; Switzerland
|
Battistella, G., Fornari, E., Thomas, A., Mall, J. - F., Chtioui, H., Appenzeller, M., et al. (2013). Weed or Wheel! fMRI, behavioural, and toxicological investigations of how cannabis smoking affects skills necessary for driving. Plos One, 8(1; 02.01.2013), 15.
Abstract: Marijuana is the most widely used illicit drug, however its effects on cognitive functions underling safe driving remain mostly unexplored. Our goal was to evaluate the impact of cannabis on the driving ability of occasional smokers, by investigating changes in the brain network involved in a tracking task. The subject characteristics, the percentage of D9-Tetrahydrocannabinol in the joint, and the inhaled dose were in accordance with real-life conditions. Thirty-one male volunteers were enrolled in this study that includes clinical and toxicological aspects together with functional magnetic resonance imaging of the brain and measurements of psychomotor skills. The fMRI paradigm was based on a visuo-motor tracking task, alternating active tracking blocks with passive tracking viewing and rest condition. We show that cannabis smoking, even at low D9-Tetrahydrocannabinol blood concentrations, decreases psychomotor skills and alters the activity of the brain networks involved in cognition. The relative decrease of Blood Oxygen Level Dependent response (BOLD) after cannabis smoking in the anterior insula, dorsomedial thalamus, and striatum compared to placebo smoking suggests an alteration of the network involved in saliency detection. In addition, the decrease of BOLD response in the right superior parietal cortex and in the dorsolateral prefrontal cortex indicates the involvement of the Control Executive network known to operate once the saliencies are identified. Furthermore, cannabis increases activity in the rostral anterior cingulate cortex and ventromedial prefrontal cortices, suggesting an increase in self-oriented mental activity. Subjects are more attracted by intrapersonal stimuli (“self”) and fail to attend to task performance, leading to an insufficient allocation of task-orientedre sources and to sub-optimal performance. These effects correlate with the subjective feeling of confusion rather than with the blood level of D9-Tetrahydrocannabinol. These findings bolster the zero-tolerance policy adopted in several countries that prohibits the presence of any amount of drugs in blood while driving.
Keywords: chemical addiction; illicit drug; marijuana in any form; cannabis; tetrahydrocannabinol; AOD intoxication; AOD effects and consequences; AOD use and driving; research; brain; neuroscience (field); laws and regulations
|